Issues pertaining to the regulation of cell and gene therapy products; Issues pertaining to the biomedical research enterprise
2026 · 2nd Quarter (Apr 1 - June 30)
DANAHER CORPORATION
Filed by LEWIS-BURKE ASSOCIATES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- May 18, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- LEWIS-BURKE ASSOCIATES, LLC
- Client
- DANAHER CORPORATION
- Filing UUID
- db1d750b-d6f4-44c5-acad-a01d7f2778c8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues pertaining to the regulation of cell and gene therapy products; Issues pertaining to the biomedical research enterprise
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.